Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00336310
Status:
UNKNOWN
Last Update Posted:
2006-06-13
First Post:
2006-06-12
Brief Title:
A Double-Blind Randomized Parallel Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus Patients
Sponsor:
National Cheng-Kung University Hospital
Organization:
National Cheng-Kung University Hospital
Organization Data
Organization:
National Cheng-Kung University Hospital
Class:
OTHER
Study ID:
YSRE0001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Cheng-Kung University Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None